key: cord-1003648-o87tj86t authors: Samanta, Arijit; Mahafujul Alam, Syed Sahajada; Ali, Safdar; Hoque, Mehboob title: Analyzing the interaction of human ACE2 and RBD of spike protein of SARS-CoV-2 in perspective of Omicron variant date: 2021-12-25 journal: bioRxiv DOI: 10.1101/2021.12.23.473991 sha: 864d00bb58b0b62b899234f2204c7fc3e81c21d1 doc_id: 1003648 cord_uid: o87tj86t The newly identified Omicron (B.1.1.529) variant of Severe Acute Respiratory Syndrome Voronavirus 2 (SARS-CoV-2) has steered concerns across the world due to the possession of large number of mutations leading to high infectivity and vaccine escape potential. The Omicron variant houses 32 mutations in S protein alone. The viral infectivity is determined mainly by the ability of spike (S) protein receptor binding domain (RBD) to bind to the human Angiotensin I Converting Enzyme 2 (hACE2) receptor. In this paper, the interaction of the RBDs of SARS-CoV-2 variants with hACE2 was analyzed by using protein-protein docking and compared with the novel Omicron variant. Our findings reveal that the Omicron RBD interacts strongly with hACE2 receptor via unique amino acid residues as compared to the Wuhan and many other variants. However, the interacting residues of RBD are found to be the same in Lamda (C.37) variant. These unique binding of Omicron RBD with hACE2 suggests an increased potential of infectivity and vaccine evasion potential of the new variant. The evolutionary drive of the SARS-CoV-2 may not be exclusively driven by RBD variants but surely provides for the platform for emergence of new variants. For the last two years the World has been witnessing an unprecedented pandemic of the coronavirus disease 2019 The currently available data suggest that the Omicron has more than 50 mutations, including 32 on the Spike (S) protein alone, including amino acid substitution, deletion, and insertion (Poudel et al., 2022) . Interestingly some of these mutations and substitutions are present in the Receptor Binding Domain (RBD). These mutations are attributed for the increased rate of infection and immune evasion capacity (Quarleri et al., 2021) (Poudel et al., 2022) (Nasrin and Ali, 2021) . The SARS-RBD of S protein interacts to the extracellular peptidase domain of human Angiotensin I Converting Enzyme 2 (hACE2) receptor to mediate cell entrance. Therefore, the mutations at the RBD are expected to alter the binding efficiency with hACE2, influencing the infectivity. The current study has been designed to study the binding affinity and interaction pattern of RBD of omicron and other variants of SARS-CoV-2 with hACE2 receptor. The RDB region of B chain of S protein mainly interacts with A chain of hACE2 during infection. Therefore, only the RDB region of B chain of S protein was selected for analysis. The crystal structure of SARS-CoV-2 S protein RBD bound with hACE2 receptor was retrieved from Protein DataBank (http://www.rcsb.org/) as a reference (PDB ID: 6M0J). The hACE2 structure from the complex was extracted using BIOVIA discovery studio and assigned as chain A. Full genome sequences of 26 variants of SARS-CoV-2 described by WHO were retrieved from GISAID (https://www.gisaid.org/) (Supplementary Table S1 ) on 4 th December 2021. For the prediction of coding sequence of RDB of S protein from all variants, Multiple Sequence Alignment (MSA) were performed by using MAFFT webtool (version 7) (Katoh and Standley, 2013) . For MSA RBD of Wuhan variant (PDB ID: 6M0J) was used as a reference and RDB sequence of S protein of other 25 variants were retrieved by MAFFT webtool (version 7). The S protein sequences of all 25 variants were saved in FASTA format for further in silico studies. Due to the absence of the three-dimensional (3D) structure of RDB of S protein of all variants of SARS-CoV-2 in protein data bank (PDB), their structural models were generated using online homology modelling server, SWISS-MODEL (https://swissmodel.expasy.org/) (Waterhouse et al., 2018) . The quality of each 3D model of SARS-CoV-2 RBD generated in SWISS-MODEL server were validated by two different web servers. Structure Analysis and Verification Server (SAVES) version 5.0 (https://servicesn.mbi.ucla.edu/SAVES/) uses Ramachandran plot, ERRAT score, verify 3D score to evaluate the models. Protein Structure Analysis (ProSA)-web server (https://prosa.services.came.sbg.ac.at/prosa.php) uses Z-score (indicates the overall model quality) to evaluate the models. Docking between hACE2 and RBD of S protein of different variants of SARS-CoV-2 was performed using ClusPro server (https://cluspro.org) (Kozakov et al., 2017) . Crystal PDB structure of hACE2 was uploaded in the ClusPro server as a receptor and validated PDB structure of RBD of S protein of all variants were uploaded one by one as a ligand. Using default setting of ClusPro server docking was done between A chain (of hACE2) and B chain (of S proteins). After each docking between hACE2 and S protein of each variant, thirty cluster models had been created, of which the model with lowest energy score were selected. The selected cluster models were downloaded in PDB format for further analysis. Direct contact residues between hACE2 : RBD of S protein of 25 all variants were analysed using PDBSum (https://www.ebi.ac.uk/thorntonsrv/databases/pdbsum/Generate.html) (Laskowski, 2001) . After selecting the best cluster model of docking between hACE2 and RBD of S protein of each variant, the cluster model was uploaded in the PDBSum to analyse the interactions between them and analysed further. MGEAX was used to align the sequences of spike proteins from different variations. The phylogenetic analysis was carried out using the MGEAX neighbour-joining approach, which involved numerous comparisons. ClustalW multiple sequence alignment was used for multiple comparisons, neighbour-joining phylogenies were estimated, and 1000 bootstraps were used (Liu et al., 2020; Laskar and Ali, 2021a) . Three different phylogenetic trees were made using sequence of RBD of all variants of SARS-CoV-2, S protein of all variants of SARS-CoV-2, whole genome sequence of all variants of SARS-CoV-2. To understand the interaction between the RBD of S protein of SARS-CoV-2 variants and hACE2 receptor, the 3D structures of the variant RBD were obtained by in silico modelling. For this purpose, the retrieved RBD sequences were used to model the 3D structures in SWISS Model and validated using SAVES ver 5.0 and ProSA web server. (Biasini et al., 2014) . Further, the RBD models of all the variants showed acceptable parameters as validated in SAVES ver 5.0 and ProSA web server (Supplementary Table S3 ). The models of all variants contain greater than 78% of its residues in the allowed region, according to the Ramachandran plot (Supplementary Figure S1 ). This result further verified the protein model's high quality. These 3D structures of Spike RBD were considered for the interaction analysis with hACE2 receptor. The hACE2:RBD complex retrieved from PDB (ID: 6M0J) was analysed using PDBSum web server. For the prediction of molecular interactions between the hACE2 receptor and RBD of S protein of SARS-CoV-2, protein-protein docking was performed using ClusPro web server. In silico molecular docking is a widely employed tool to predict the protein-protein interactions (Kozakov et al., 2017) . The binding affinities of RBD across variants of SARS-CoV-2 to hACE2 were found to be different because of the sequence variations due to mutation, substitution or insertion in RBD. The binding efficiencies, represented in terms of lowest energy, between the hACE2 and variant RBDs are tabulated in with respect of Omicron variant. The protein-protein interaction between hACE2 and SARS-CoV-2 RBD was studied by performing molecular using ClusPro server (https://cluspro.org) and analysed in PDBSum. The number of interacting residues were calculated and identical residues to that of Omicron variant were calculated. This study further envisaged to investigate the pattern of interactions of RBD variants with hACE2 as this interaction is a crucial point for the viral infectivity. To analyse the amino acid residues involved in direct interaction between RBD and hACE2, PDBSum (https://www.ebi.ac.uk/thornton-srv/databases/pdbsum/Generate.html) web server was used. The probable interacting residues of both the interacting partners were obtained in 2D format. All these interactions are presented in Supplementary Figure S2 . From these results the interacting amino acids of RDB of all variants were extracted. Similarly, the interacting amino acids of hACE2 to the RDB were also extracted. To understand the extent and diversity of these interactions, the interacting residues were closely analysed. The interacting amino acid residues of RBD of Omicron is compared with other 25 variants (including Wuhan Variant). The RBD of Omicron variant interacts using 30 amino acid residues with 41 residues on hACE2. These residues of Omicron RBD are completely different from those of Wuhan variant (Figure 1A) . Similarly, the omicron variant uses unique binding residues than thirteen more variants. However, some variants show similarity binding residues with the Omicron. For instance, the Lamda variant (C.37) RBD interacts with the hACE2 with 100% identical residues with that of Omicron variant ( Figure 1A ). Other variants like C.1.2 and Beta (B.1.351) used 92.86% and 90.33% identical residues to that of Omicron RBD to interact with hACE2. Furthermore, we examined the interacting residues of hACE2 involved in binding the RDBs of different variations. The Beta variant (B.1.351) was found to interact with the hACE2 on 58.93% identical residues that are recognized by the Omicron RBD ( Figure 1B) . More than half (51.1%) of the amino acid residues of hACE2 to which the Omicron interacts are identical to that of the C.1.2 variant. The resemblance between the Omicron and the rest of the variants is less than 50% in the recognizing residues on hACE2. The interaction of hACE2 with Omicron variant RBD was compared with all other variant RBDs and the relative number of identical residues are presented in Supplementary Table S4 . This is the first report encompassing comparative analysis of interacting residues of RBD of variants and hACE2. The present dataset demonstrates that the novel variant, Omicron, interacts with unique residues to new amino acid residues in the hACE2 receptor, raising the question of infectivity, vaccination potential and immune evasion. A recent study based on hACE: RBD interaction, suggested that the Omicron variant show over ten times higher infectivity than the Wuhan variant, are capable of escape currently available vaccines and efficacy of neutralizing monoclonal antibodies (Chen et al., 2021) supporting our prediction. The interaction of hACE with S protein RBD of Omicron variant and three variants with over ninety percent identical residues as Omicron namely Beta (B.1.351), Lamda (C.37) and C.1.2, are shown in Figure 2 . The interaction of Wuhan variant (WIV04) was represented as reference. Moreover, the 3D illustrations of the corresponding interactions are shown in Figure 3 . available which are not listed as WHO variants (Rambaut et al., 2020; Ali, 2021a, 2021b) . The present study along with the available records suggests a probability for the incidence of mutations in the lineages with higher infectivity that will eventually emerge as a novel variant in near future. Viruses are continually evolving due to mutations in their genetic coding as they spread and in the process creating a roadmap for evolving and varying pathological manifestations (Laskar and Ali, 2021c) . To understand the evolution pattern of RBD of Omicron variant, the phylogenetic tree was prepared along with other variants using MEGA X software (Figure 4) . Omicron variant is similarly distantly localized in the phylogenetic tree based on S protein sequence but has different companions ( Figure 4B) . The above observations signify that even though evolution is being driven by mutations across the genome, the ones affecting the RBD-hACE2 interaction have a greater probability of emerging as new variant. The Omicron variant interacts with the hACE2 receptor with strong affinity involving unique amino acid residues than most of the SARS-CoV-2 variants suggesting increased infectivity and immune/vaccine evasion potential of the variant. However, the Lamda variant (C.37) interacts with hACE2 with higher affinity using identical RBD residues of the Omicron. This study calls for a closer observation on the evolution of SARS-CoV-2 with the genomic alterations affecting the RBD:hACE2 interaction as the key basis for monitoring. Toward the estimation of the absolute quality of individual protein structure models SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information Omicron (B.1.1.529): Infectivity, vaccine breakthrough, and antibody resistance MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability The ClusPro web server for protein-protein docking Phylo-geo-network and haplogroup analysis of 611 novel coronavirus (SARS-CoV-2) genomes from India Mutational analysis and assessment of its impact on proteins of SARS-CoV-2 genomes from India Differential mutation profile of SARS-CoV-2 proteins across deceased and asymptomatic patients PDBsum: summaries and analyses of PDB structures Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2 Genetic Path of the Emergence of SARS-CoV-2. Gene Cell Tissue In Press Omicron variant sparks significant concern among global experts -What is known so far Omicron variant of the SARS-CoV-2: a quest to define the consequences of its high mutational load. GeroScience A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology SWISS-MODEL: homology modelling of protein structures and complexes The authors are thankful to the Department of Biological Sciences, Aliah University, Kolkata, India for providing the necessary facilities for this work. SSMA acknowledges the Council of The authors declare that there exists no conflict of interests.